StockData
Oragenics Inc logo

Oragenics Inc (OGEN) stock

OGENNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 1/30
$0.19−0.02 (-10.00%)

Close on Nov 18, 2026Market cap $852.76KP/E –Yield –

Oragenics net income

Net income is the profit left for shareholders after every expense, interest and tax.

Oragenics's net income for the twelve months ending Jun 30, 2026 was -$10.08M. For fiscal 2025 it was -$9.84M. The highest annual figure on record is -$5.79M in fiscal 2014.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$9.84M–
FY2024Dec 31, 2024-$10.57M–
FY2023Dec 31, 2023-$20.66M–
FY2022Dec 31, 2022-$14.29M–
FY2021Dec 31, 2021-$15.71M–
FY2020Dec 31, 2020-$26.43M–
FY2019Dec 31, 2019-$15.57M–
FY2018Dec 31, 2018-$9.91M–
FY2017Dec 31, 2017-$6.73M–
FY2016Dec 31, 2016-$7.01M–
FY2015Dec 31, 2015-$11.71M–
FY2014Dec 31, 2014-$5.79M–
FY2013Dec 31, 2013-$16.07M–
FY2012Dec 31, 2012-$13.09M–
FY2011Dec 31, 2011-$7.68M–
FY2010Dec 31, 2010-$7.81M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$2.53M–
Q1 FY2026Mar 31, 2026-$2.20M–
Q4 FY2025Dec 31, 2025-$2.29M–
Q3 FY2025Sep 30, 2025-$3.07M–
Q2 FY2025Jun 30, 2025-$2.27M–
Q1 FY2025Mar 31, 2025-$2.22M–
Q4 FY2024Dec 31, 2024-$3.35M–
Q3 FY2024Sep 30, 2024-$2.46M–
Q2 FY2024Jun 30, 2024-$2.31M–
Q1 FY2024Mar 31, 2024-$2.45M–
Q4 FY2023Dec 31, 2023-$12.75M–
Q3 FY2023Sep 30, 2023-$2.01M–
Q2 FY2023Jun 30, 2023-$3.05M–
Q1 FY2023Mar 31, 2023-$2.84M–
Q4 FY2022Dec 31, 2022-$2.24M–
Q3 FY2022Sep 30, 2022-$3.87M–
Q2 FY2022Jun 30, 2022-$3.59M–
Q1 FY2022Mar 31, 2022-$4.59M–
Q4 FY2021Dec 31, 2021-$2.29M–
Q3 FY2021Sep 30, 2021-$4.38M–
Q2 FY2021Jun 30, 2021-$3.82M–
Q1 FY2021Mar 31, 2021-$5.22M–
Q4 FY2020Dec 31, 2020-$4.41M–
Q3 FY2020Sep 30, 2020-$4.50M–
Q2 FY2020Jun 30, 2020-$12.34M–
Q1 FY2020Mar 31, 2020-$5.19M–
Q4 FY2019Dec 31, 2019-$3.60M–
Q3 FY2019Sep 30, 2019-$3.84M–
Q2 FY2019Jun 30, 2019-$4.81M–
Q1 FY2019Mar 31, 2019-$3.33M–
Q4 FY2018Dec 31, 2018-$2.76M–
Q3 FY2018Sep 30, 2018-$2.76M–
Q2 FY2018Jun 30, 2018-$2.28M–
Q1 FY2018Mar 31, 2018-$2.12M–
Q4 FY2017Dec 31, 2017-$1.46M–
Q3 FY2017Sep 30, 2017-$2.07M–
Q2 FY2017Jun 30, 2017-$1.22M–
Q1 FY2017Mar 31, 2017-$1.98M–
Q4 FY2016Dec 31, 2016-$2.67M–
Q3 FY2016Sep 30, 2016-$1.96M–

More Oragenics figures

See a number that looks wrong?